{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T16:18:11Z","timestamp":1778257091226,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Abbott Medical Netherlands","award":["E-APC 2023-HF-79"],"award-info":[{"award-number":["E-APC 2023-HF-79"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neth Heart J"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The accessibility of left ventricular assist device (LVAD) therapy is a\u00a0crucial factor in the survival and quality of life of patients suffering from advanced heart failure. However, there is a\u00a0lack of clarity regarding the utilization of this therapy across regions in the Netherlands as well as whether any disparities exist based on socioeconomic status (SES). This study aimed to determine the utilization of LVAD therapy at a\u00a0regional level using administrative data and to identify potential disparities based on SES by comparing postal code data to demographic governmental data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>All patients aged 16 or older who underwent a\u00a0primary LVAD implantation between 2015 and 2024 were included. The data was visualized with a\u00a0heatmap using Python.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A\u00a0total of 710 patients received an LVAD during the study period. LVAD utilization was lower in the southernmost regions compared to the northernmost regions and varied in the central regions. An ANOVA test between SES groups did not show significant differences in LVAD utilization (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u20090.20).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The findings of this study indicate that there are notable variations in the utilization of LVAD therapy across different geographical regions in the Netherlands. Nevertheless, no differences in LVAD use were found between areas with different SES categories. Future research should focus on identifying the underlying factors associated with referral for advanced heart failure therapies to ensure equitable access to LVAD therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12471-026-02019-9","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T06:34:22Z","timestamp":1770705262000},"page":"100-106","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Left ventricular assist device utilization across the different regions of the Netherlands"],"prefix":"10.1007","volume":"34","author":[{"given":"Val\u00e9rie C. E.","family":"Drost","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maaike","family":"W\u00f6sten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luuk C.","family":"Otterspoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Damman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurens F.","family":"Tops","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Gianoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiel","family":"Kuijpers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meindert","family":"Palmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelena","family":"Sjatskig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aria P.","family":"Yazdanbakhsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kadir","family":"Caliskan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda W.","family":"Van Laake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"2019_CR1","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.athoracsur.2020.12.038","volume":"111","author":"EJ Molina","year":"2021","unstructured":"Molina\u00a0EJ, Shah\u00a0P, Kiernan\u00a0MS, et\u00a0al. The society of thoracic surgeons intermacs 2020 annual report. Ann Thorac Surg. 2021;111:778\u201392.","journal-title":"Ann Thorac Surg"},{"key":"2019_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.15420\/ecr.2019.29.2","volume":"15","author":"A Bayes-Genis","year":"2020","unstructured":"Bayes-Genis\u00a0A, Mu\u00f1oz-Guijosa\u00a0C, Santiago-Vacas\u00a0E, et\u00a0al. Destination therapy with left ventricular assist devices in non-transplant centres: the time is right. Eur Cardiol Rev. 2020;15:105\u20138.","journal-title":"Eur Cardiol Rev"},{"key":"2019_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.athoracsur.2022.11.023","volume":"115","author":"M Yuzefpolskaya","year":"2023","unstructured":"Yuzefpolskaya\u00a0M, Schroeder\u00a0SE, Houston\u00a0BA, et\u00a0al. The society of thoracic surgeons Intermacs 2022 annual report: focus on the 2018 heart transplant allocation system. Ann Thorac Surg. 2023;115:311\u201327.","journal-title":"Ann Thorac Surg"},{"key":"2019_CR4","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1001\/jama.2022.16197","volume":"328","author":"MR Mehra","year":"2022","unstructured":"Mehra\u00a0MR, Goldstein\u00a0DJ, Cleveland\u00a0JC, et\u00a0al. Five-year outcomes in patients with fully magnetically levitated vs axial-flow left ventricular assist devices in the MOMENTUM 3 randomized trial. JAMA. 2022;328:1233\u201342.","journal-title":"JAMA"},{"key":"2019_CR5","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1002\/ehf2.14444","volume":"10","author":"L Numan","year":"2023","unstructured":"Numan\u00a0L, Schramm\u00a0R, Oerlemans\u00a0M, et\u00a0al. Survival after HeartMate 3\u00a0left ventricular assist device implantation: real-world data from Europe. ESC Heart Fail. 2023;10:2754\u20136.","journal-title":"ESC Heart Fail"},{"key":"2019_CR6","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/eurheartj\/ehad658","volume":"45","author":"JD Schmitto","year":"2024","unstructured":"Schmitto\u00a0JD, Shaw\u00a0S, Garbade\u00a0J, et\u00a0al. Fully magnetically centrifugal left ventricular assist device and long-term outcomes: the ELEVATE registry. Eur Heart\u00a0J. 2024;45:613\u201325.","journal-title":"Eur Heart J"},{"key":"2019_CR7","first-page":"189","volume":"31","author":"K Damman","year":"2023","unstructured":"Damman\u00a0K, Caliskan\u00a0K, Birim\u00a0O, et\u00a0al. Left ventricular assist device implantation and clinical outcomes in the Netherlands. Neth Heart\u00a0J. 2023;31:189\u201395.","journal-title":"Neth Heart J"},{"key":"2019_CR8","unstructured":"Rijksinstituut voor Volksgezondheid en Milieu. Ranglijsten - Wat zijn de belangrijkste doodsoorzaken? 2023. https:\/\/www.vzinfo.nl\/ranglijsten\/sterfte#:~:text=In%202023%20overleden%20in%20Nederland,hartziekten%20(ruim%208.000)%20en%20hartfalen. Accessed 4 Dec 2024."},{"key":"2019_CR9","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/ejhf.1236","volume":"20","author":"MG Crespo-Leiro","year":"2018","unstructured":"Crespo-Leiro\u00a0MG, Metra\u00a0M, Lund\u00a0LH, et\u00a0al. Advanced heart failure: a\u00a0position statement of the heart failure association of the European society of cardiology. Eur J Heart Fail. 2018;20:1505\u201335.","journal-title":"Eur J Heart Fail"},{"key":"2019_CR10","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.cardfail.2021.06.003","volume":"27","author":"MR Mehra","year":"2021","unstructured":"Mehra\u00a0MR, Gustafsson\u00a0F. Left ventricular assist devices at the crossroad of innovation in advanced heart failure. J\u00a0Card Fail. 2021;27:1291\u20134.","journal-title":"J Card Fail"},{"key":"2019_CR11","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.jacc.2020.01.034","volume":"75","author":"M Guglin","year":"2020","unstructured":"Guglin\u00a0M, Zucker\u00a0MJ, Borlaug\u00a0BA, et\u00a0al. Evaluation for heart transplantation and LVAD implantation: JACC council perspectives. J\u00a0Am Coll Cardiol. 2020;75:1471\u201387.","journal-title":"J Am Coll Cardiol"},{"key":"2019_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1136\/heartjnl-2020-317216","volume":"107","author":"B Schrage","year":"2021","unstructured":"Schrage\u00a0B, Lund\u00a0LH, Benson\u00a0L, et\u00a0al. Lower socioeconomic status predicts higher mortality and morbidity in patients with heart failure. Heart. 2021;107:229\u201336.","journal-title":"Heart"},{"key":"2019_CR13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/ejcts\/ezx320","volume":"53","author":"T de By","year":"2018","unstructured":"de By\u00a0T, Mohacsi\u00a0P, Gahl\u00a0B, et\u00a0al. The European registry for patients with mechanical circulatory support (EUROMACS) of the European association for cardio-thoracic surgery (EACTS): second report. Eur J Cardiothorac Surg. 2018;53:309\u201316.","journal-title":"Eur J Cardiothorac Surg"},{"key":"2019_CR14","unstructured":"Centraal Bureau voor Statistiek. Overledenen; belangrijke doodsoorzaken (korte lijst), regio. 2024. https:\/\/www.cbs.nl\/nl-nl\/cijfers\/detail\/80202ned. Accessed 25 Oct 2024."},{"key":"2019_CR15","unstructured":"Centraal Bureau voor Statistiek. Sociaal Economische Status per Postcode 2019. 2024. https:\/\/www.cbs.nl\/nl-nl\/maatwerk\/2022\/26\/sociaal-economische-status-per-postcode-2019. Accessed 25 Oct 2024."},{"key":"2019_CR16","unstructured":"Centraal Bureau voor Statistiek. Berekenwijze Sociaal Economische Status scores. 2021. https:\/\/www.cbs.nl\/nl-nl\/maatwerk\/2021\/45\/berekenwijze-ses-score-per-wijk-buurt. Accessed 25 Oct 2024."},{"key":"2019_CR17","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1002\/ejhf.2143","volume":"23","author":"PM Seferovic","year":"2021","unstructured":"Seferovic\u00a0PM, Vardas\u00a0P, Jankowska\u00a0EA, et\u00a0al. The heart failure association atlas: heart failure epidemiology and management statistics 2019. European J of Heart Fail. 2021;23:906\u201314.","journal-title":"European J of Heart Fail"},{"key":"2019_CR18","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/ejhf.975","volume":"20","author":"LH Lund","year":"2018","unstructured":"Lund\u00a0LH, Trochu\u00a0JN, Meyns\u00a0B, et\u00a0al. Screening for heart transplantation and left ventricular assist system: results from the ScrEEning for advanced Heart Failure treatment (SEE-HF) study. Eur J Heart Fail. 2018;20:152\u201360.","journal-title":"Eur J Heart Fail"},{"key":"2019_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.3489","author":"G Baudry","year":"2024","unstructured":"Baudry\u00a0G, Metra\u00a0M, Delmas\u00a0C. Reply to the letter regarding the article \u2019Are mechanical circulatory supports the forgotten aspect in the implementation of therapies for heart failure?\u2019. Eur J Heart Fail. 2024; https:\/\/doi.org\/10.1002\/ejhf.3489.","journal-title":"Eur J Heart Fail"},{"key":"2019_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14986","author":"A Shakoor","year":"2024","unstructured":"Shakoor\u00a0A, van Maarschalkerwaart\u00a0WA, Schaap\u00a0J, et\u00a0al. Socio-economic inequalities and heart failure morbidity and mortality: a\u00a0systematic review and data synthesis. ESC Heart Fail. 2024; https:\/\/doi.org\/10.1002\/ehf2.14986.","journal-title":"ESC Heart Fail"},{"key":"2019_CR21","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.recesp.2021.11.027","volume":"75","author":"TA McDonagh","year":"2022","unstructured":"McDonagh\u00a0TA, Metra\u00a0M, Adamo\u00a0M, et\u00a0al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC) with the special contribution of the heart failure association (HFA) of the ESC. Rev Esp Cardiol. 2022;75:523.","journal-title":"Rev Esp Cardiol"},{"key":"2019_CR22","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.healun.2017.02.010","volume":"36","author":"J Baumwol","year":"2017","unstructured":"Baumwol\u00a0J. \u201cI Need Help\u201d-a mnemonic to aid timely referral in advanced heart failure. J\u00a0Heart Lung Transplant. 2017;36:593\u20134.","journal-title":"J Heart Lung Transplant"},{"key":"2019_CR23","doi-asserted-by":"publisher","first-page":"e238","DOI":"10.1161\/CIR.0000000000001016","volume":"144","author":"AA Morris","year":"2021","unstructured":"Morris\u00a0AA, Khazanie\u00a0P, Drazner\u00a0MH, et\u00a0al. Guidance for timely and appropriate referral of patients with advanced heart failure: a\u00a0scientific statement from the American heart association. Circulation. 2021;144:e238\u2013e50.","journal-title":"Circulation"},{"key":"2019_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezae285","author":"VCE Drost","year":"2024","unstructured":"Drost\u00a0VCE, Otterspoor\u00a0LC, Zijderhand\u00a0CF, et\u00a0al. Shared care for patients with a\u00a0left ventricular assist device: a\u00a0scoping review. Eur J Cardiothorac Surg. 2024; https:\/\/doi.org\/10.1093\/ejcts\/ezae285.","journal-title":"Eur J Cardiothorac Surg"},{"key":"2019_CR25","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s12471-024-01912-5","volume":"32","author":"P van der Harst","year":"2024","unstructured":"van der Harst\u00a0P, Damman\u00a0P, de Groot\u00a0JR, et\u00a0al. Advancing cardiovascular care-key insights from the Netherlands Heart Journal 2024. Neth Heart\u00a0J. 2024;32:429\u201332.","journal-title":"Neth Heart J"},{"key":"2019_CR26","unstructured":"Dutch Cardiovascular Alliance. Heart4Data. 2022. https:\/\/dcvalliance.nl\/our-consortia\/heart4data\/. Accessed 8 Oct 2025."}],"container-title":["Netherlands Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-026-02019-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12471-026-02019-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-026-02019-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T13:19:13Z","timestamp":1771507153000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12471-026-02019-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["2019"],"URL":"https:\/\/doi.org\/10.1007\/s12471-026-02019-9","relation":{},"ISSN":["1568-5888","1876-6250"],"issn-type":[{"value":"1568-5888","type":"print"},{"value":"1876-6250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"assertion":[{"value":"14 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"V.C.E.\u00a0Drost: received an Educational Grant from Abbott Medical Netherlands; L.C.\u00a0Otterspoor: received speaker fees from Abbott, and the Catharina Hospital and Eindhoven University of Technology received a Perseus PPS Grant; K.\u00a0Damman: received speaker\/consultancy fees from Abbott, Boehringer Ingelheim, Novartis, Astra Zeneca, Echosense and Reprieve; L.F.\u00a0Tops: received speaker fees from Medtronic; M.\u00a0Gianoli: board member of the ISMICS, Member of the EACTS endorsed Robotic Task force in Cardio Thoracic Surgery and member of the Medical Advice Board of the Octovascular; L.W.\u00a0van Laake: serves as an editor for the Netherlands Heart Journal and the UMC Utrecht received speaker fees from CVOI, Medcon and Abbott, a\u00a0non-financial grant from Medtronic and a\u00a0Health Holland PPS Grant from Abbott; all other authors: none declared. M.\u00a0W\u00f6sten, M.\u00a0Kuijpers, M.\u00a0Palmen, J.\u00a0Sjatskig, A.P.\u00a0Yazdanbakhsh and K.\u00a0Caliskan declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}